The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF).
 
Yasser Ged
No Relationships to Disclose
 
Andrea Knezevic
No Relationships to Disclose
 
Yingbei Chen
No Relationships to Disclose
 
Almedina Redzematovic
No Relationships to Disclose
 
Maria Isabel Carlo
No Relationships to Disclose
 
Chung-Han Lee
Consulting or Advisory Role - Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Pfizer (Inst)
 
Darren R. Feldman
Research Funding - Novartis; Seagen
 
Sujata Patil
No Relationships to Disclose
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Alexion Pharmaceuticals; Calithera Biosciences; Exelixis; GlaxoSmithKline; Natera; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Novartis; Takeda